Cargando…

Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights

Peripheral neurotoxicity is one of the most distressing side effects of oxaliplatin therapy for cancer. Indeed, most patients that received oxaliplatin experience acute and/or chronic severe sensory peripheral neuropathy. However, despite similar co-morbidities, cancer stage, demographics and treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marmiroli, Paola, Riva, Beatrice, Pozzi, Eleonora, Ballarini, Elisa, Lim, Dmitry, Chiorazzi, Alessia, Meregalli, Cristina, Distasi, Carla, Renn, Cynthia L., Semperboni, Sara, Morosi, Lavinia, Ruffinatti, Federico A., Zucchetti, Massimo, Dorsey, Susan G., Cavaletti, Guido, Genazzani, Armando, Carozzi, Valentina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636145/ https://www.ncbi.nlm.nih.gov/pubmed/29020118 http://dx.doi.org/10.1371/journal.pone.0186250

Ejemplares similares

Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity
por: Dionisi, Marianna, et al.
Publicado: (2023)

Oxaliplatin induces pH acidification in dorsal root ganglia neurons
por: Riva, Beatrice, et al.
Publicado: (2018)

Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
por: Ballarini, Elisa, et al.
Publicado: (2022)

Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
por: Canta, Annalisa, et al.
Publicado: (2020)

Reply to a Comment Paper on the Published Paper by Canta, A. et al: “Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity”—Antioxidants 2020, 9, 594
por: Canta, Annalisa, et al.
Publicado: (2020)

Early Stimulation of TREK Channel Transcription and Activity Induced by Oxaliplatin-Dependent Cytosolic Acidification
por: Dionisi, Marianna, et al.
Publicado: (2020)

Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity
por: Chiorazzi, Alessia, et al.
Publicado: (2015)

Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity
por: Pozzi, Eleonora, et al.
Publicado: (2023)

Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity
por: Meregalli, Cristina, et al.
Publicado: (2021)

Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
por: Cavaletti, Guido, et al.
Publicado: (2021)

High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats
por: Meregalli, Cristina, et al.
Publicado: (2018)

Reversal of Bortezomib-Induced Neurotoxicity by Suvecaltamide, a Selective T-Type Ca-Channel Modulator, in Preclinical Models
por: Meregalli, Cristina, et al.
Publicado: (2021)

Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin
por: Hucke, Anna, et al.
Publicado: (2023)

Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy
por: Pozzi, Eleonora, et al.
Publicado: (2023)

Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice
por: Renn, Cynthia L, et al.
Publicado: (2011)

Bortezomib Treatment Produces Nocifensive Behavior and Changes in the Expression of TRPV1, CGRP, and Substance P in the Rat DRG, Spinal Cord, and Sciatic Nerve
por: Quartu, M., et al.
Publicado: (2014)

Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity
por: Zhu, Jing, et al.
Publicado: (2016)

Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect
por: Malacrida, A., et al.
Publicado: (2021)

Bortezomib-Induced Painful Peripheral Neuropathy: An Electrophysiological, Behavioral, Morphological and Mechanistic Study in the Mouse
por: Carozzi, Valentina A., et al.
Publicado: (2013)

Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2020)

Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats
por: Canta, Annalisa, et al.
Publicado: (2022)

CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats
por: Meregalli, Cristina, et al.
Publicado: (2012)

Assessment of a Silicon-Photomultiplier-Based Platform for the Measurement of Intracellular Calcium Dynamics with Targeted Aequorin
por: Ruffinatti, Federico Alessandro, et al.
Publicado: (2020)

Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain
por: Bloomingdale, Peter, et al.
Publicado: (2022)

Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
por: Tesei, Anna, et al.
Publicado: (2019)

An Overview of Bortezomib-Induced Neurotoxicity
por: Meregalli, Cristina
Publicado: (2015)

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
por: Argyriou, Andreas A.
Publicado: (2015)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2021)

Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria
por: Alberti, Paola, et al.
Publicado: (2022)

Toxicities of Therapeutic Agents Used in Medicine
por: Carozzi, Valentina Alda, et al.
Publicado: (2016)

Proteomic analysis links alterations of bioenergetics, mitochondria-ER interactions and proteostasis in hippocampal astrocytes from 3xTg-AD mice
por: Dematteis, Giulia, et al.
Publicado: (2020)

Oxaliplatin neurotoxicity – no general ion channel surface-charge effect
por: Broomand, Amir, et al.
Publicado: (2009)

The Use of Calcium and Magnesium to Prevent Neurotoxicity in Patients Receiving Oxaliplatin
por: Martyn, Karon, et al.
Publicado: (2015)

Memantine ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection
por: Wang, Youyu, et al.
Publicado: (2022)

A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice
por: Calls, Aina, et al.
Publicado: (2022)

Dose Effects of Oxaliplatin on Persistent and Transient Na(+) Conductances and the Development of Neurotoxicity
por: Park, Susanna B., et al.
Publicado: (2011)

Efficacy of Exercise Rehabilitation Program in Relieving Oxaliplatin Induced Peripheral Neurotoxicity
por: Gui, Qi, et al.
Publicado: (2021)

Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity
por: Nepal, Mahesh R., et al.
Publicado: (2022)

HDACi: The Columbus’ Egg in Improving Cancer Treatment and Reducing Neurotoxicity?
por: Squarzoni, Angelica, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
por: Canta, Annalisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uemnn40fiamkrbivbluftuap3b